Marc Werner

Marc Werner is the CEO of Galenica, a leading Swiss healthcare company that recently reported its first revenue exceeding 4 billion Swiss francs in 2025. Under his leadership, Galenica has focused on the Swiss domestic market, successfully navigating challenges such as the U.S. tariff disputes and capitalizing on the growing demand for expensive therapies, including weight loss injections. Werner has emphasized the company's strategy to expand its pharmacy network and diversify its services, including offering vaccinations and medical lab operations, positioning Galenica as a key player in the Swiss healthcare sector.